Reliable Performance
Absolute Accountability
Devices and Diagnostics
- Prosthetics
- Cardiovascular
- Ophthalmic Devices
- Medicinal Injectors
- Imaging Scans
- Medicinal Pumps
Vaccines-Immunology
- Hepatitis B; HBsAg, HBcAb and HBsAb, C. Diff and HCab
- HAP
- HIV
- Influenza
Gastroenterology
- Opioid Induced Constipation
- Digestive Disorder (GERD)
- Irritable Bowel Syndrome
- Colon Enteritis
Oncology Neurology Endocrine Cardiology
Orphan Drug Development/Compassionate Use Monitoring
As scientists and physicians learn more about the mechanisms of rare disease states they inevitably encounter molecular structures that may not hold the potential for treating more common disorders, but offer promising and sustainable benefit for irregularities that affect a smaller population with inherently unique complications.
Orphan drug development requires an impassioned and dedicated approach that takes years of specialized testing and examination to qualify for immediate use when no other options are available. Scrutinizing observation is imperative to ensure that these formulations deliver the intended benefits.
ProClinical Research Consultants know that no matter how direct, potent and efficacious a therapeutic may be, without a team of experienced, efficient and committed monitors to validate the findings, that molecule may not meet its mark.
ProClinical Research Consultants intensely focus on the results of the molecule’s activity at every level of response and the concomitant associates that affect it. Reporting the findings exactly as they exist, accounting for all therapeutic reactions to represent a concise and detailed description for scientific analysis is the deliverable that encompasses our mission.